NCT02119832View on ClinicalTrials.gov

A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Chronic Kidney Disease (CKD)
Interventions
DEVICE

Endovasccular AVF (EndoAVF)

The FLEX System will be used to endovascularly create a fistula in CKD patients who require hemodialysis vascular access

Trial Locations (1)

1001-1925

Italian Hospital, Asunción

All Listed Sponsors
lead

TVA Medical Inc.

INDUSTRY

NCT02119832 - A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR) | Biotech Hunter | Biotech Hunter